LACTO-N-FUCOPENTAOSE I

LNF-1 LNF I LNFP I LACTO-N-FUCOPENTAOSE-1 LACTO-N-FUCOPENTAOSE I IV2FUC-LCOSE4 LACTO-N-FUCOPENTAOSE I FROM HUMAN MILK α-l-fuc (1→2)-β-d-gal-(1→3)-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4R,5R)-6-hydroxy-1-oxo-2,4-bis[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxyoxan-3-yl]acetamide LNFP I, α-L-Fuc (1-2)-β-D-Gal-(1-3)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc Lacto-N-fucopentaose I (LNFP I) alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Lacto-N-fucopentaose Ⅰ ALPHA-L-FUC [1->2]-BETA-D-GAL-[1->3]-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Lacto-N-neofucopentaose I (LnNFP-I) Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)- Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc Fucα1,2Galβ1,3GlcNAcβ1,3Galβ1,4Glc Blood group O(H) type I determinant D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→2)-O-β-D-galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)- Lacto-N-fucopentaose I / Blood group H antigen pentaose type 1 (LNFP-I) 7578-25-8 Carbohydrate Standards Carbohydrate Analysis Carbohydrates BioChemical Biochemicals and Reagents Post-translational Modification Proteomics P to Q Proteomics and Protein Expression Proteasome inhibitor Disaccharide D to K Enzyme Inhibitors Enzyme Inhibitors by Enzyme Enzymes, Inhibitors, and Substrates Guanylate cyclase